A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

Clinical trial NCT06854640 · RECRUITING

Trial details

NCT number: NCT06854640
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sepsis Coagulopathy

Start date: 2025-03-12
Primary completion: 2026-12-25
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.